Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2021.631233 http://scihub22266oqcxt.onion/10.3389/fimmu.2021.631233 33643316!7907157!33643316     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2021 ; 12 (ä): 631233 Nephropedia Template TP {{tp|p=33643316|t=2021. The Immunopathology of COVID-19 and the Cannabis Paradigm |pdf=|usr=}}{{33643316}} gab.com Text The Immunopathology of COVID-19 and the Cannabis Paradigm JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33643316 #FOAvip Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of 24th January 2021. SARS-CoV2 targets the lower respiratory tract system leading to pneumonia with fever, cough, and dyspnea. Most patients develop only mild symptoms. However, a certain percentage develop severe symptoms with dyspnea, hypoxia, and lung involvement which can further progress to a critical stage where respiratory support due to respiratory failure is required. Most of the COVID-19 symptoms are related to hyperinflammation as seen in cytokine release syndrome and it is believed that fatalities are due to a COVID-19 related cytokine storm. Treatments with anti-inflammatory or anti-viral drugs are still in clinical trials or could not reduce mortality. This makes it necessary to develop novel anti-inflammatory therapies. Recently, the therapeutic potential of phytocannabinoids, the unique active compounds of the cannabis plant, has been discovered in the area of immunology. Phytocannabinoids are a group of terpenophenolic compounds which biological functions are conveyed by their interactions with the endocannabinoid system in humans. Here, we explore the anti-inflammatory function of cannabinoids in relation to inflammatory events that happen during severe COVID-19 disease, and how cannabinoids might help to prevent the progression from mild to severe disease. Twit Text FOAVip The Immunopathology of COVID-19 and the Cannabis Paradigm ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33643316 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33643316 #FOAvip English Wikipedia <ref>{{Cite pmid|33643316}}</ref> The Immunopathology of COVID-19 and the Cannabis Paradigm #MMPMID33643316 Paland N; Pechkovsky A; Aswad M; Hamza H; Popov T; Shahar E; Louria-Hayon I Front Immunol 2021[]; 12 (ä): 631233 PMID33643316show ga Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of 24th January 2021. SARS-CoV2 targets the lower respiratory tract system leading to pneumonia with fever, cough, and dyspnea. Most patients develop only mild symptoms. However, a certain percentage develop severe symptoms with dyspnea, hypoxia, and lung involvement which can further progress to a critical stage where respiratory support due to respiratory failure is required. Most of the COVID-19 symptoms are related to hyperinflammation as seen in cytokine release syndrome and it is believed that fatalities are due to a COVID-19 related cytokine storm. Treatments with anti-inflammatory or anti-viral drugs are still in clinical trials or could not reduce mortality. This makes it necessary to develop novel anti-inflammatory therapies. Recently, the therapeutic potential of phytocannabinoids, the unique active compounds of the cannabis plant, has been discovered in the area of immunology. Phytocannabinoids are a group of terpenophenolic compounds which biological functions are conveyed by their interactions with the endocannabinoid system in humans. Here, we explore the anti-inflammatory function of cannabinoids in relation to inflammatory events that happen during severe COVID-19 disease, and how cannabinoids might help to prevent the progression from mild to severe disease. |*Phytotherapy[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |COVID-19/*therapy[MESH] |Cannabinoids/*therapeutic use[MESH] |Cannabis/*immunology[MESH] |Cytokine Release Syndrome/*therapy[MESH] |Endocannabinoids/metabolism[MESH] |Humans[MESH] |Pandemics[MESH]The Immunopathology of COVID-19 and the Cannabis Paradigm (epmc).pdf DeepDyve Pubget Overpricing